Anti-Acod1 siRNA-loaded lipid nanoparticles for liver cancer treatment
Abstract 241877 Introduction: Recent studies provide substantial evidence supporting Cis-aconitate decarboxylase 1 (Acod1) as a potential target for cancer immunotherapy....
AntiAcod1
